Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
106.7544
1.4784 EUR
216.38 M EUR
4.13 B EUR
133.77 M
About Galderma Group AG
Sector
Industry
CEO
Flemming Ørnskov
Website
Headquarters
Zug
Founded
1981
ISIN
CH1335392721
Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
XS302520585
Galderma Finance Europe B.V. 3.5% 20-MAR-2030Yield to maturity
3.26%
Maturity date
Mar 20, 2030
GAD251
Galderma Holding SA 1.8098% 18-MAR-2033Yield to maturity
1.15%
Maturity date
Mar 18, 2033
GAD241
Galderma Holding SA 1.9% 27-SEP-2032Yield to maturity
1.07%
Maturity date
Sep 27, 2032
GAD25
Galderma Holding SA 1.4025% 20-MAR-2029Yield to maturity
0.79%
Maturity date
Mar 20, 2029
GAD24
Galderma Holding SA 1.6% 27-SEP-2028Yield to maturity
0.72%
Maturity date
Sep 27, 2028
See all A407X6 bonds
Frequently Asked Questions
The current price of A407X6 is 158.6000 EUR — it has increased by 1.33% in the past 24 hours. Watch Galderma Group AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSX exchange Galderma Group AG stocks are traded under the ticker A407X6.
A407X6 stock has risen by 0.88% compared to the previous week, the month change is a 5.19% rise, over the last year Galderma Group AG has showed a 38.18% increase.
We've gathered analysts' opinions on Galderma Group AG future price: according to them, A407X6 price has a max estimate of 200.65 EUR and a min estimate of 118.57 EUR. Watch A407X6 chart and read a more detailed Galderma Group AG stock forecast: see what analysts think of Galderma Group AG and suggest that you do with its stocks.
A407X6 reached its all-time high on Oct 31, 2025 with the price of 159.7000 EUR, and its all-time low was 114.7800 EUR and was reached on May 30, 2025. View more price dynamics on A407X6 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
A407X6 stock is 1.65% volatile and has beta coefficient of 1.14. Track Galderma Group AG stock price on the chart and check out the list of the most volatile stocks — is Galderma Group AG there?
Today Galderma Group AG has the market capitalization of 36.23 B, it has decreased by −5.20% over the last week.
Yes, you can track Galderma Group AG financials in yearly and quarterly reports right on TradingView.
Galderma Group AG is going to release the next earnings report on Mar 5, 2026. Keep track of upcoming events with our Earnings Calendar.
A407X6 earnings for the last half-year are 1.18 EUR per share, whereas the estimation was 0.99 EUR, resulting in a 19.31% surprise. The estimated earnings for the next half-year are 1.27 EUR per share. See more details about Galderma Group AG earnings.
Galderma Group AG revenue for the last half-year amounts to 2.08 B EUR, despite the estimated figure of 2.02 B EUR. In the next half-year revenue is expected to reach 2.35 B EUR.
A407X6 net income for the last half-year is 178.97 M EUR, while the previous report showed 170.63 M EUR of net income which accounts for 4.88% change. Track more Galderma Group AG financial stats to get the full picture.
Yes, A407X6 dividends are paid annually. The last dividend per share was 0.16 EUR. As of today, Dividend Yield (TTM)% is 0.10%. Tracking Galderma Group AG dividends might help you take more informed decisions.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Galderma Group AG EBITDA is 959.02 M EUR, and current EBITDA margin is 21.34%. See more stats in Galderma Group AG financial statements.
Like other stocks, A407X6 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Galderma Group AG stock right from TradingView charts — choose your broker and connect to your account.